Earnings Call · Q3 FY2021·2021-10-26

Q3 21EPS -1.02%·Rev n/aQ2 21EPS -1.06%·Rev n/aQ1 21EPS -10.95%·Rev n/aQ4 20EPS +15.06%·Rev n/a⚠ consensus missing

ELI LILLY & Co LLY

Kevin Hearn — Vice President, Investor Relations

David Ricks — Chairman and Chief Executive Officer

Anat Ashkenazi — Chief Financial Officer

Dr. Dan Skovronsky — Chief Scientific and Medical Officer

+1.4%1d on move date+1.3% vs SPY3d+3.4%5d+1.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LLY calls or request research access.

More LLY calls Browse calls Request research access